BioNTech SE Noncurrent Liabilities
BioNTech SE (BNTX) had Noncurrent Liabilities of EUR 622.10 million as of 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Notes
ifrs-full:NoncurrentLiabilities · last filed 2026-03-10
- 2025-12-31: Noncurrent Liabilities 622.10M EUR.
- 2024-12-31: Noncurrent Liabilities 595.40M EUR.
- 2023-12-31: Noncurrent Liabilities 689.90M EUR.
- 2022-12-31: Noncurrent Liabilities 272.90M EUR.
| Period end | Noncurrent Liabilities | Noncurrent Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 622.10M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 595.40M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 689.90M EUR 20-F · filed 2025-03-10 | |
| 2022-12-31 | 272.90M EUR 20-F · filed 2024-03-20 | |
| 2021-12-31 | 455.50M EUR 20-F · filed 2023-03-27 | |
| 2020-12-31 | 340.80M EUR 20-F/A · filed 2022-10-26 | 340.76M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 166.01M EUR 20-F · filed 2021-03-30 | |
| 2018-12-31 | 259.87M EUR 20-F · filed 2020-03-31 |